OWC Pharmaceutical Research Corp (OWCP)

[kbaz]

OWCP may have just become the most Transparent Penny OTC in History...With the exception of what they have in the cellar as far as IP.

[I-Glow]

LMAO! That is always the response from those uninformed about how the the SEC operates. Show me a link - read the complaint - OWCP provided a Fraudulent Opinion Letter...

OWCP is finished - it could be suspended any day and then the same nonsense will be spewed - management is going to get this resolved in a few days - management is going to file a lawsuit against the SEC...

IG

[Hercules1]

Up, up, and away.

[skitahoe]

I have to wonder if this would have happened if Friedland had been an expert and adviser to a company doing something that was viewed as completely legal by the Federal Govt. I'm not saying it wouldn't have happened, and don't know if he could possibly do jail time, but if he does, their is something seriously wrong when all sorts of people who brought down the economy back in 2008 got a slap on the hands, but someone who did something wrong, but was involved in cannabis got the book thrown at him.

I'm not a fan of Friedland, don't like what he did at all, but right now it's the SEC action that's hurting us, not what he did. Long term none of us like down day's, week's, or month's, but if you didn't sell, no damage has yet been done. I believe at the end of the year we should be substantially higher as I believe Hirsch and expect we'll be getting some positive news several times this year. While I'm uncertain that any of the news will indicate product sales being initiated this year, I still believe they'll be quite positive, and at the end of the year we'll be substantially higher than we started at the beginning.

By the end of the year, I doubt if the SEC actions will have any influence on the share price, but of course this can never be proven because it has happened. No matter how high we are at the end of the year, some could allege that we'd be higher had it not been for the SEC action. This is a non problem and like most non problems, it can never be completely dismissed.

Gary

[I-Glow]

Hirsch either lied in the 8-K or isn't conversant about the SEC in terms of litigation.

OWCP was indeed implicated in the SEC compliant against Friedland - but you were also very giddy about Friedland pumping OWCP at one time - so the motivation to ignore the facts are to preserve your investment.

This is proof OWCP was involved in the pump and dump.

"OWC provided an attorney opinion letter to OWC’s transfer agent from a disbarred attorney in connection with the issuance of OWC’s stock to Global."

Why would OWCP provide a Fraudulent Opinion to benefit Friedland - if they weren't complicit in the scam - the answer is that OWCP is part of the scam.

IG

[Farmer7]

Provide a link that states the investigation is expanding.

[icgreen22]

MM OTCX has been on the ask all week,but just switched over to the bid.Anyone know anything about this mm?

[ddbl_our_buck]

..goin through old friedland posts!
Lol
Link back! Memories..
$OWCP

[icgreen22]

My bad,wrong one:)

[icgreen22]

Here's the one I meant to post:)
PETACH TIKVA, Israel, March 8, 2018 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a chairman's statement to shareholders.

In the light of recent events, and the numerous communications we have received from shareholders, I would like to address this statement to the Shareholders of OWCP (the "Company").

The Company is committed to building a leadership position in the medical cannabis market and to our mission of improving patients' lives through the development of new solutions, products and devices derived from and delivery mechanisms for the use of medical cannabis.

We have recruited a highly skilled management team with multi-year experience in medical cannabis, pharmaceutical development, corporate management and capital markets.

As we have stated in our 8-K filing of today, we are neither a party to the pending SEC action against a former adviser to the Company, nor is the Company alleged to have been a party to nor had any knowledge of the purported scheme by the former adviser, who is the subject of the SEC action.

The Company's management is committed to and focused on our development programs which are continuing as per plan. These include inter alia, our current safety trial for our cannabis cream; the approval processes to initiate a safety trial for our oral disintegrating tablet and additional pipeline projects.

As a management team, we are committed to building value for our shareholders though professional, ethical and strategic management of a technology platform that we believe will bring improved health and quality of life to millions of patients around the world. We have recently announced the addition of our new Chief Scientific Officer and we continue to develop the resources we believe will bolster our endeavors in creating a great company.

Yours sincerely,

Dr. Stanley Hirsch
Chairman of the Board

[ddbl_our_buck]

..5 mil shares for Two years consulting fee?? Didn’t they notice he NEVER said anything in regard to OWC except when referencing others along with it. I found that very odd at the time ~ advisory board?? Lol
I hope Mr. Bignitz or Dr. Hirsch would expect more from a consultant?? Which I’m sure they do. The 8k is very real and affects so many lives. What a dirt bag! Burn his book ! Friedland Capital? Repent!!
$OWCP

[gruber72]

Why would "he" (presumably Friedland) be "listed as Investor's Relations with a contact phone number?" I'm not sure I understand your premise.

Are you saying that Friedland, this paid promoter who was not an OWCP employee, was listed as part of their Investor Relations? That makes no sense and I have no reason to believe he was unless someone can show me proof.

I agree that something was going on -- Friedland was a scumbag who was selling into the weed frenzy and egging it on with his own press. I still see no blame landing on OWCP. I personally hope some of these threads lead to the investigation of the Market Makers, who are as dirty as they come.

[I-Glow]

That isn't close to being accurate - I have seen hundreds of SEC investigations - helped start many and the SEC complaint is civil - that is always how they start.

There wasn't a press release about the litigation - it was found through a court filing - which means the investigation is just beginning.

The SEC will turn this over to the Justice Department - where there will be criminal indictments - which always takes longer.

The SEC language in the complaint clearly shows that OWCP insiders were involved in the share selling scheme.

As I stated OWCP was created at a dinner at Friedland's house - so he was involved from the beginning.

Friedland was selling OWCP stock through September 2017.

There is at least $2.3 million dollars not accounted for in the complaint - we will find out how much made it back to the OWCP insiders.

Since Friedland just resigned from the Advisory Board - it is impossible to try and put the blame on "old management".

Sorry but this investigation is just beginning.

IG

[ddbl_our_buck]

hey Alex! You’re a fine man and wish you best in everything you do and undertake. Thanks for being here!
$OWCP

[Choney]

Nothing has changed. The potential of the companies products is unchanged. Some here will try to turn this thing into a catastrophe but it is not. We will recover and we will be stronger than ever before. I'm holding.

[Cherry]

You know I have to say I am glad OWC had NOTHING to do with it. I like many here probably did not sleep well last night.

I was praying OWC came out with news today that they are clean in this matter and are moving forward. I am happy for us all.

Long OWCP

Cherry

[AlexSwiss]

Wrong, people beleive on facts, in fact we are GREEN AND SOLID TRADING TODAY
From today 8k:
“The Registrant(OWCP) has not been named as a party to the pending SEC action nor is the Registrant alleged to have been a party to nor had any knowledge of the purported scheme by the Friedland Defendants.”

[ddbl_our_buck]

Tiger comeback = OWC rebound!
(One under thru 2)
Grip and rip Tiger, I mean owc..
$$OWCP

[KrakenTaken]

when u get free shares its all profit... this guy got 5.1m for nothing for touting being a bloe hard... while us hard workers loaded up using our paycheck money and got dumped on... EVEN IF OWCP WAS GETTING AHEAD OF THEMSELVES we had a core position of the float LOCKED.. and got chit on

[I-Glow]

Many claimed that Friedland wasn't a insider - but oddly he just resigned from the Advisory board.

"OWC Pharmaceutical Research Corp. (the “Registrant”) is filing this Form 8-K to report the resignation of Mr. Jeffrey Friedland (“Mr. Friedland”) as a member of the Registrant’s Advisory Board, effective immediately. A copy of Mr. Friedland’s letter of resignation is attached as exhibit 17.5 to this Form 8-K."

Although, OWCP supplied Friedland with a Fraudulent Opinion Letter written by a disbarred attorney - and that Friedland hosted the dinner that started OWCP... But he wasn't a insider - now that is completely ignoring the facts.

Some are trying to convince investors that OWCP was duped - sorry but the facts clearly show that OWCP was complicit in the share selling scheme.

OWCP was setup as a pump and dump from the beginning.

IG

[Wormking777]

Already did like I’ve done previously. Lol.

[ddbl_our_buck]

..so, has JF has made his last trade in owc? What about Gwp$ ntva? What about those stupid interviews he does on pot network ? I can’t watch them. They are history. Where is Greenberg his partner in 2014? Israel?? Syria? Hangin with Ziv? Hirsch must be furious! Alan and Yehuda! These are incredible people! Mr. Big! ~ their bios ring all bells! New and exciting Chief Science officer?? They’ll get off their hands eventually bc the blood will quit! Protect your IP Yehuda! God Bless you and OWC! That’s why I came here almost two years ago, R and D in weed! It’s happening !Faith baby!
Shabbat shalom

[Jakelegal]

Very good points.

He seem to have been selling before the run up and after the fall. Sounds like he just wanted to get rid of them regardless of what the price was.

That's particularly distressing - because he may have known that they were years away from producing anything of value- but it may simply be that he needed the money to satisfy his new extravagant lifestyle

[ChillinCharlie]

JF commented to a few people at the conference in 2017 that OWCP, CNBX and a few others were getting ahead of themselves. He thought the fundamentals didn’t support a $3 OWCP but everyone was caught up in the excitement of legalized MMJ and the ETFs that were supposed to include OWCP. He could have been selling on his past experience watching these pot stocks tank in 2014 but why not do it legally??? Sever ties. Sell your millions. I don’t think it would have changed most Longs mind. They were set on believing this was the next GW

[Jakelegal]

If OWCP were at fault they would have NECESSARILY have been included in this litigation. End of story.

Read the complaint for yourself and don't rely on this board :

https://businessden.com/wp-content/uploads/2018/03/Friedland-SEC.pdf

[John Kent]

They sure did they loaded up on private placements while Jeff was dumping let us not forget Jeff traded on inside info and someone on the inside and some brokers knew when news was coming. This all makes many wonder why the timelines are all way off now

[AlexSwiss]

Amazing volume today stronger than yesterday and we are green!!
Soon Chart will speak for itself and haters gonna hate more!

OWCP $$$$

[kbaz]

HAHA! Short it! Why tell everyone?

[surfgreen]

I dare you to short this.

[Wormking777]

Life is great . Shorting this is even better. See you at the Grey Market.

[ddbl_our_buck]

..link above.. from sept 17, 2017

To our Shareholders,
Following my recent appointment as Chairman at OWC Pharma (OTCQB: OWCP), it is my pleasure to introduce myself to you and to initiate a new tradition of biannual shareholder update letters.
On the personal front, I am a biologist by training with a D. Phil. Degree from Oxford University in Cell Biology and Immunology. I have been involved in diagnostics, pharmaceutical and biotechnology (medical and agricultural) companies at CEO level since 1989 and I have run both private and public companies in this sector in Brazil, China, England, Israel and the United States. My roles in these companies have included operational and strategic elements. I currently serve as CEO of FuturaGene Ltd., an agricultural biotech company. I have been the manager of the company since its inception, leading it through a series of private fundings, a reverse merge on the AIM Exchange of the London Stock Market, a successful secondary offering in London and the ultimate sale of the company to Suzano Pulp and Paper in Brazil in a cash transaction which valued the company at US $100 million. As CEO of FuturaGene, I successfully obtained the first ever regulatory approval to commercially deploy a genetically modified commercial tree species. In addition to my role as Chairman at OWC Pharma, I also currently serve as Chairman at Foamix Pharmaceuticals (NASDAQ: FOMX), a specialty dermatology company, inter alia. In my early years as an Executive Director at Foamix, I was responsible for European Business Development, and in this role, I cemented an out-licensing deal with Bayer Pharmaceuticals for the development and commercialization of a topical drug for Rosacea. Marketing of this drug was initiated in late 2015 after FDA approval and today yields multi-million dollar annual royalties to Foamix. In my role as a Director and Chairman at Foamix, I have been actively involved in Foamix's IPO and two follow-on offerings on NADAQ, which in aggregate raised approximately $170 million. I believe that the experience I have acquired in these endeavors will be a strong factor in assisting in the development of OWC Pharma.

It has also been my pleasure to work closely in the past with Mr. Mordechai Bignitz, our CEO. I believe that our complementary skills and our proven ability to work successfully together will play a very positive role in helping take our company to new levels of achievement.

Research and Development

Our company is focusing on developing high level cannabis-based products for dealing with unmet medical needs in specific fields. In this respect, we have progressed in a number of areas over the last 8 months:

During this period, we completed a pre-clinical efficacy study in psoriasis with unique, and what we believe may be breakthrough results; we previously reported an up to 70% reduction in biological markers directly related to this disease;
We have received the first ever Institutional Review Board (IRB) approval to conduct a safety study for a cannabis-based topical cream with more than 3% THC and we are actively conducting a safety study (FDA Phase 1 equivalent) in one of the biggest academic hospitals in Israel. We will update the public with material developments in this area as they occur.
We filed for intellectual property (IP) protection for various delivery methods to treat different diseases, a very rare approach in the medical marijuana industry; the attainment of IP protection could represent a significant asset for our company;
We have completed the development of an orally disintegrating tablet, an important new delivery form;
Our topical cream for Psoriasis is market ready
We reported on status in our Multiple Myeloma program and we will continue to report on any material progress in that connection

Our research activities are led by Dr. Yehuda Baruch. Dr. Baruch served as Head of the Israeli Ministry of Health's Medical Marijuana Program from 2003 through 2013 where he spearheaded the efforts on regulation, chaired the indication committee, secured Helsinki Approvals for medical research, and managed regulation of patient licensing and dosage. He has extensive experience in researching medical cannabis, most notably for its effect on PTSD. Dr. Baruch is a globally acknowledged expert in the field of medical marijuana. His contributions and expertise have been and will continue to be a major factor in our development as one of the leaders in this field and provide strong scientific basis to all our endeavors. As Chairman, it has been my privilege to work with Dr. Baruch in advancing our company.

Note to our Shareholders: Further to the above report, we will, in general, provide broad guidance on our development timetables, but we will do this with due caution as the course of research and development is, by nature, uncertain - it is difficult to put a precise timeline on scientific studies. We will not provide responses to individual approaches between our public communications.

Corporate level & Business Development

Business Development:

General
Cannabis for medical purposes (also known as "medical Cannabis") is a new and infant industry with no internationally accepted standards or protocols. Many states that implemented or are about to implement Medical Cannabis bills are still to determine and pass formal sets of regulations, especially when related to products (such as our Topical cream for skin conditions), that include 3% THC or more. We are now in the process of completing a strategic analysis to determine the optimal markets and the best possible way to penetrate these markets. In this context:

We have taken proactive steps in various territories including, but not limited to appointing Mediq as our market access consultant for Germany;
We are exploring other potential markets and maintaining an ongoing dialogue with various potential business partners including representatives, manufacturers and distributors.
Corporate level

Our senior management team has been strengthened by the inclusion of two experienced professionals: Mr. Yossi Dagan, CPA (IL), as our Chief Financial Officer (CFO) and myself, as your Chairman.
We have paid down all outstanding debt and the company is now well positioned to deploy capital solely for its development needs;
We announced our initiative to cross-list our stock to the TSX and we are evaluating the possibility of cross-listing our stock on additional exchanges to increase trading liquidity as well as to facilitate our ability to raise capital to enhance our development and commercialization efforts.
As a management team, it is our vision to develop OWC Pharma as the leading cannabis-based specialty pharma company. Over the last few months we have executed on a number of important steps in order to fulfill this vision. We appreciate your continued support and interest in OWC Pharma as we move along this pathway to help patients improve their quality of life with validated and tested medication and to create value for our shareholders.

I look forward to updating you in the future,

Yours sincerely,

Dr. Stanley Hirsch,

Chairman

Notice Regarding Forward-Looking Statements
This Letter to Shareholders contains 'forward-looking statements' as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this Letter, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, filing patent applications, product development, and business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in OWC Pharmaceutical Research Corp. (OTCQB: OWCP) reports filed with the Securities and Exchange Commission.


Contact Information:
Mordechai Bignitz
Chairman and CEO
E-mail: [e-mail]
Tel: [phone]

SOURCE OWC Pharmaceutical Research Corp.

Also from this source


10:31 ET
OWC Pharmaceutical Research Corp. Issues Chairman's Statement to...


FEB 20, 2018, 08:30 ET
OWC Pharmaceutical Research Corp. Appoints Dr. Oron Yacoby Zeevi...

Explore

More news releases in similar topics

Biotechnology
Health Care & Hospitals
Medical Pharmaceuticals
Pharmaceuticals
Accounting News & Issues
You just read:

OWC Pharma Issues Chairman's Letter to Shareholders

NEWS PROVIDED BY
OWC Pharmaceutical Research Corp.
Sep 14, 2017, 07:00 ET


PR Newswire

[Hercules1]

Buying is picking up today.

[Hercules1]

It is ready to rock.

Dollar land is coming here.


These are good buying opportunities.

[icgreen22]

Ok,didn't see those.

[trading.jeff]

$OWCP A couple of decent size trades in the past several minutes:

One was for 22500 shares at .2669, equal to ~$6K.

Another was for 30100 shares at .267, equal to ~$8K.

[DonLoki]

I know about that !

Someone here talked about having private emails with a owcp management about buying the stock and other stuff

[icgreen22]

https://www.prnewswire.com/news-releases/owc-pharma-issues-chairmans-letter-to-shareholders-644386203.html

[DonLoki]

What was it then ? i can’t remember

[MjMilo]

Item 8.01. Other Events.



OWC Pharmaceutical Research Corp. (the “Registrant”) is filing this Form 8-K to report the resignation of Mr. Jeffrey Friedland (“Mr. Friedland”) as a member of the Registrant’s Advisory Board, effective immediately. A copy of Mr. Friedland’s letter of resignation is attached as exhibit 17.5 to this Form 8-K.



The Registrant has been made aware of the fact that the United States Securities and Exchange Commission (the “SEC”) has commenced a civil injunctive action against Mr. Friedland and two related entities (the “Friedland Defendants”) by the filing of a complaint in the United States District Court for the District of Colorado. The SEC alleges in the complaint that the Friedland Defendants “engaged in a nearly $7 million securities fraud scheme to conceal the nature of [Mr. Friedland’s] interest in . . . OWC Pharmaceutical Research Corp. (“OWC”) to allow him to unload his considerable holdings in OWC stock into the marked that he helped to artificially inflate.”



The Registrant has not been named as a party to the pending SEC action nor is the Registrant alleged to have been a party to nor had any knowledge of the purported scheme by the Friedland Defendants.



The Registrant is aware that Mr. Friedland, through one of his entities, was an early investor in the Registrant, having purchase more than 1.3 million shares of the Registrant’s common stock in 2014 in a private placement. In addition, in February 2016, Mr. Friedland was issued an additional 5.1 million shares through another of his entities (both of which are Friedland Defendants) as compensation for a two-year consulting agreement with the Registrant which agreement expired by its terms in February 2018.



The Registrant did not receive any of the proceeds from the sale by the Friedland Defendants of the OWC shares nor did the Registrant benefit by the alleged scheme by the Friedland Defendants. The registrant with its legal advisors continues to consider additional actions if and so required.


To suggest that OWCP has any wrongdoing in this SEC action is pure unsubstantiated speculation and is neither supported in the sec complaint nor in the 8K put out by the registrant.

[KrakenTaken]

you're correct sir cream is market ready hence last step is safety study test of actual cream that will go 2 market.. impressive trading so far today held the .20 level lets see

[KrakenTaken]

lmfaoooooo

[MjMilo]

Um...no

Here is the list of defendants.

OWCP is not named.


Aspen Upper Ranch LLC
Defendant
Assurance Management LLC
Defendant
Jeffrey O Friedland
Defendant
Kathy B. Friedland
Defendant
Global Corporate Strategies LLC
Defendant
Intiva Pharma LLC
Defendant
Lane 6552 LLC
Defendant
The Jeffrey and Kathy Friedland Irrevocable Trust

[AlexSwiss]

Watch out !!
BIG VOLUME
CHART REVERSED
-8K clearly states OWCP is out from this
-UPTREND movement triggered after confirmed bottom
-Golden cross
-Pharma+ Trial News

OWCP LING AND STRONG

[icgreen22]

He wasn't talking about emails,lol.

[I-Glow]

Where is the efficacy report that was supposed to be completed a year ago?

OWCP hasn't produced anything - except pumping press releases and 8-Ks.

Where is the published research?

OWCP doesn't have any assets - they don't own any patents.

OWCP paid a well known penny stock pumper for "investor relations" - and 5.1 million shares for his pumping.

It is ignoring the facts to think the SEC isn't continuing the investigation.

The facts are that OWCP hasn't produced anything but a pump and dump.

IG

[ddbl_our_buck]

kraken, it’s cream ok ? Not creme if you get it right, you may have lol more credence. Loving my 23’s from yesterday to add to my three accounts. You add?
$OWCP

[AlexSwiss]

As always your statement is false OWCP not the defendant, and they are not part of the fraud.
In addition Markwt understands and we are green

[TKO600]

Copy that swamp boy!! For those of us who are still in support of the company , pipeline and Israel in general, take a look in the Bible at Gen.12:1-3. I'm still gonna hold ....against that little voice saying SELLLLL!! I'm tooooo far upside down to sell. It just may be that what was meant for harm ,turns into good for us longs and most importantly ,for the company and future shareholders . I do hope that the leadership will vet prospective employees, business partners and advisors with a microscope from now on. Good LUCK TO ALL ON HOW THIS SHAKES OUT. We'll need it.
TKO

[DonLoki]

Post the emails!

[Mistafixit]

Cream has to be market ready for IRB testing imo